-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Pharvaris, Lowers Price Target to $74

Benzinga·05/13/2026 14:28:17
Listen to the news
Citizens analyst Jonathan Wolleben maintains Pharvaris (NASDAQ:PHVS) with a Market Outperform and lowers the price target from $75 to $74.